Evidence for Altered Glutamine Metabolism in Human Immunodeficiency Virus Type 1 Infected Primary Human CD4+ T Cells. 2017

Andrea Hegedus, and Maia Kavanagh Williamson, and Mariam B Khan, and Julianna Dias Zeidler, and Andrea T Da Poian, and Tatiana El-Bacha, and Eduard A Struys, and Hendrik Huthoff
1 Department of Infectious Diseases, King's College London , London, United Kingdom .

Glutamine is a conditionally essential amino acid that is an important metabolic resource for proliferating tissues by acting as a proteinogenic amino acid, a nitrogen donor for biosynthetic reactions and as a substrate for the citric acid or tricarboxylic acid cycle. The human immunodeficiency virus type 1 (HIV-1) productively infects activated CD4+ T cells that are known to require glutamine for proliferation and for carrying out effector functions. As a virus, HIV-1 is furthermore entirely dependent on host metabolism to support its replication. In this study, we compared HIV-1 infected with uninfected activated primary human CD4+ T cells with regard to glutamine metabolism. We report that glutamine concentrations are elevated in HIV-1-infected cells and that glutamine is important to support HIV-1 replication, although the latter is closely linked to the glutamine dependency of cell survival. Metabolic tracer experiments showed that entry of glutamine-derived carbon into the citric acid cycle is unaffected by HIV-1 infection, but that there is an increase in the secretion of glutamine-derived glutamic acid from HIV-1-infected cells. Western blotting of key enzymes that metabolize glutamine revealed marked differences in the expression of glutaminase isoforms, KGA and CAG, as well as the PPAT enzyme that targets glutamine-derived nitrogen toward nucleotide synthesis. Altogether, this demonstrates that infection of CD4+ T cells with HIV-1 leads to considerable changes in the cellular glutamine metabolism.

UI MeSH Term Description Entries
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005973 Glutamine A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells. D-Glutamine,L-Glutamine,D Glutamine,L Glutamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D064368 Healthy Volunteers Persons with no known significant health problems who are recruited to participate in research to test a new drug, device, or intervention as controls for a patient group. (from http://clinicalcenter.nih.gov/recruit/volunteers.html, accessed 2/14/2013) Healthy Participants,Healthy Subjects,Human Volunteers,Normal Volunteers,Healthy Participant,Healthy Subject,Healthy Volunteer,Human Volunteer,Normal Volunteer,Participant, Healthy,Participants, Healthy,Subject, Healthy,Subjects, Healthy,Volunteer, Healthy,Volunteer, Human,Volunteer, Normal,Volunteers, Human,Volunteers, Normal

Related Publications

Andrea Hegedus, and Maia Kavanagh Williamson, and Mariam B Khan, and Julianna Dias Zeidler, and Andrea T Da Poian, and Tatiana El-Bacha, and Eduard A Struys, and Hendrik Huthoff
December 2000, The Journal of infectious diseases,
Andrea Hegedus, and Maia Kavanagh Williamson, and Mariam B Khan, and Julianna Dias Zeidler, and Andrea T Da Poian, and Tatiana El-Bacha, and Eduard A Struys, and Hendrik Huthoff
October 1992, Journal of virology,
Andrea Hegedus, and Maia Kavanagh Williamson, and Mariam B Khan, and Julianna Dias Zeidler, and Andrea T Da Poian, and Tatiana El-Bacha, and Eduard A Struys, and Hendrik Huthoff
January 2014, PloS one,
Andrea Hegedus, and Maia Kavanagh Williamson, and Mariam B Khan, and Julianna Dias Zeidler, and Andrea T Da Poian, and Tatiana El-Bacha, and Eduard A Struys, and Hendrik Huthoff
August 1999, Journal of virology,
Andrea Hegedus, and Maia Kavanagh Williamson, and Mariam B Khan, and Julianna Dias Zeidler, and Andrea T Da Poian, and Tatiana El-Bacha, and Eduard A Struys, and Hendrik Huthoff
April 2005, Clinical and diagnostic laboratory immunology,
Andrea Hegedus, and Maia Kavanagh Williamson, and Mariam B Khan, and Julianna Dias Zeidler, and Andrea T Da Poian, and Tatiana El-Bacha, and Eduard A Struys, and Hendrik Huthoff
January 2009, Journal of virology,
Andrea Hegedus, and Maia Kavanagh Williamson, and Mariam B Khan, and Julianna Dias Zeidler, and Andrea T Da Poian, and Tatiana El-Bacha, and Eduard A Struys, and Hendrik Huthoff
February 1992, The Journal of biological chemistry,
Andrea Hegedus, and Maia Kavanagh Williamson, and Mariam B Khan, and Julianna Dias Zeidler, and Andrea T Da Poian, and Tatiana El-Bacha, and Eduard A Struys, and Hendrik Huthoff
November 1995, Journal of virology,
Andrea Hegedus, and Maia Kavanagh Williamson, and Mariam B Khan, and Julianna Dias Zeidler, and Andrea T Da Poian, and Tatiana El-Bacha, and Eduard A Struys, and Hendrik Huthoff
April 2011, Clinical and experimental immunology,
Andrea Hegedus, and Maia Kavanagh Williamson, and Mariam B Khan, and Julianna Dias Zeidler, and Andrea T Da Poian, and Tatiana El-Bacha, and Eduard A Struys, and Hendrik Huthoff
October 2005, Journal of virology,
Copied contents to your clipboard!